REFERENCES
- Budd R. J., Hughes I. C., Smith J. A. Health beliefs and compliance with antipsychotic medication. The British Journal of Clinical Psychology 1996; 35(3)393–397, [PUBMED], [INFOTRIEVE]
- Coldham E. L., Addington J., Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica Acta 2002; 106(4)286–290, [CROSSREF]
- Dolder C. R., Lacro J. P., Dunn L. B., Jeste D. V. Antipsychotic medication adherence: Is there a difference between typical and atypical agents?. The American Journal of Psychiatry 2002; 159(1)103–108, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Everitt B. S., Landau S. The use of multivariate statistical methods in psychiatry. Statistical Methods in Medical Research 1998; 7(3)253–277, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Harvey P. D., Green M. F., Keefe R. S., Velligan D. I. Cognitive functioning in schizophrenia: A consensus statement on its role in the definition and evaluation of effective treatments for the illness. The Journal of Clinical Psychiatry 2004; 65(3)361–372, [PUBMED], [INFOTRIEVE]
- Kampman O., Laippala P., Vaananen J., Koivisto E., Kiviniemi P., Kilkku N., Lehtinen K. Indicators of medication compliance in first-episode psychosis. Psychiatry Research 2002; 110(1)39–48, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kay S. R., Fiszbein A., Opler L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13(2)261–276, [PUBMED], [INFOTRIEVE]
- Kay S. R., Opler L. A., Lindenmayer J. P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Research 1988; 23(1)99–110, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kay S. R., Opler L. A., Lindenmayer J. P. The Positive and Negative Syndrome Scale (PANSS): Rationale and standardisation. The British Journal of Psychiatry 1989, Suppl(7): 59–67, [CSA]
- Kay S. R., Opler L. A., Spitzer R. L., Williams J. B., Fiszbein A., Gorelick A. SCID-PANSS: Two-tier diagnostic system for psychotic disorders. Comprehensive Psychiatry 1991; 32(4)355–361, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kemp R., Hayward P., Applewhaite G., Everitt B., David A. Compliance therapy in psychotic patients: Randomised controlled trial. British Medical Journal 1996; 312(7027)345–349, [PUBMED], [INFOTRIEVE]
- Kemp R., Kirov G., Everitt B., Hayward P., David A. Randomised controlled trial of compliance therapy. 18-month follow-up. The British Journal of Psychiatry 1998; 172: 413–419, [PUBMED], [INFOTRIEVE], [CSA]
- Kozuki Y., Froelicher E. S. Lack of awareness and nonadherence in schizophrenia. Western Journal of Nursing Research 2003; 25(1)57–74, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lacro J. P., Dunn L. B., Dolder C. R., Leckband S. G., Jeste D. V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. The Journal of Clinical Psychiatry 2002; 63(10)892–909, [PUBMED], [INFOTRIEVE], [CSA]
- Leucht S., Barnes T. R., Kissling W., Engel R. R., Correll C., Kane J. M. Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials. The American Journal of Psychiatry 2003; 160(7)1209–1222, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lindstrom E., Wieselgren I. M., von Knorring L. Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia. Acta Psychiatrica Scandinavica 1994; 89(3)192–195, [PUBMED], [INFOTRIEVE]
- Lloyd A., Horan W., Borgaro S. R., Stokes J. M., Pogge D. L., Harvey P. D. Predictors of medication compliance after hospital discharge in adolescent psychiatric patients. The Journal of Child and Adolescent Psychopharmacology 1998; 8(2)133–141
- Loffler W., Kilian R., Toumi M., Angermeyer M. C. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 2003; 36(3)105–112, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McQuaid J. R., Granholm E., McClure F. S., Roepke S., Pedrelli P., Patterson T. L., Jeste D. V. Development of an integrated cognitive-behavioral and social skills training intervention for older patients with schizophrenia. The Journal of Psychotherapy Practice and Research 2000; 9(3)149–156, [PUBMED], [INFOTRIEVE], [CSA]
- Mutsatsa S. H., Joyce E. M., Hutton S. B., Webb E., Gibbins H., Paul S., Barnes T. R. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scandinavica 2003; 108(6)439–446, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Novak-Grubic V., Tavcar R. Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. European Psychiatry 2002; 17(3)148–154, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- O'Donnell C., Donohoe G., Sharkey L., Owens N., Migone M., Harries R., Kinsella A., Larkin C., O'Callaghan E. Compliance therapy: A randomised controlled trial in schizophrenia. British Medical Journal 2003; 327(7419)834, [PUBMED], [INFOTRIEVE]
- Olfson M., Mechanic D., Hansell S., Boyer C. A., Walkup J., Weiden P. J. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Pschiatric Services 2000; 51(2)216–222, [CROSSREF]
- Pekkala E., Merinder L. Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews (2) 2002, Retrieved CD002831
- Robinson D. G., Woerner M. G., Alvir J. M., Bilder R. M., Hinrichsen G. A., Lieberman J. A. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research 2002; 57(2–3)209–219, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rossell S. L., Coakes J., Shapleske J., Woodruff P. W., David A. S. Insight: Its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychological Medicine 2003; 33(1)111–119, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shin S. K., Lukens E. P. Effects of psychoeducation for Korean Americans with chronic mental illness. Psychiatric Services 2002; 53(9)1125–1131, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Turkington D., Kingdon D., Turner T. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. The British Journal of Psychiatry. 2002; 180: 523–527, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vauth R., Loschmann C., Rusch N., Corrigan P. W. Understanding adherence to neuroleptic treatment in schizophrenia. Psychiatry Research 2004; 126(1)43–49, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Velligan D. I., Miller A. L. Cognitive dysfunction in schizophrenia and its importance to outcome: The place of atypical antipsychotics in treatment. The Journal of Clinical Psychiatry 1999; 60(Suppl 23)25–28, [PUBMED], [INFOTRIEVE]
- Velligan D. I., Newcomer J., Pultz J., Csernansky J., Hoff A. L., Mahurin R., Miller A. L. Does cognitive function improve with quetiapine in comparison to haloperidol?. Schizophrenia Research 2002; 53(3)239–248, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Velligan D. I., Prihoda T. J., Ritch J. L., Maples N., Bow-Thomas C. C., Dassori A. A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophrenia Bulletin 2002; 28(2)283–292, [PUBMED], [INFOTRIEVE], [CSA]
- Velligan D. I., Prihoda T. J., Sui D., Ritch J. L., Maples N., Miller A. L. The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. The Journal of Clinical Psychiatry 2003; 64(5)524–531, [PUBMED], [INFOTRIEVE], [CSA]
- Weiden P., Rapkin B., Mott T., Zygmunt A., Goldman D., Horvitz-Lennon M., Frances A. Rating of medication influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin 1994; 20(2)297–310, [PUBMED], [INFOTRIEVE], [CSA]
- Weiden P. J., Mackell J. A., McDonnell D. D. Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research 2004; 66(1)51–57, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Weiden P. J., Olfson M. Cost of relapse in schizophrenia. Schizophrenia Bulletin 1995; 21(3)419–429, [PUBMED], [INFOTRIEVE], [CSA]
- Weiss K. A., Smith T. E., Hull J. W., Piper A. C., Huppert J. D. Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schizophrenia Bulletin 2002; 28(2)341–349, [PUBMED], [INFOTRIEVE], [CSA]